Users Online: 108 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 66  |  Issue : 4  |  Page : 522-523

Malaria hemozoin: A target for point-of-care diagnosis

Senior Research Fellow, ICMR-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh; Scientist B, ICMR-National Institute of Malaria Research, New Delhi, India

Correspondence Address:
Shrikant Nema
ICMR-National Institute of Malaria Research, New Delhi - 110 077
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijph.ijph_1646_21

Rights and Permissions

The challenges in malaria diagnosis continue to threaten the malaria elimination goal in India and other malaria-endemic countries. A rapid diagnostic test (RDT) kit is widely used in resource-constrained areas where microscopy and molecular methods are not easily deployable. Considering the problems associated with the currently available RDT kit, such as histidine-rich protein 2 gene deletion and prolonged stability of the protein in the blood, it suggests that new potential biomarkers are urgently needed. Hemozoin (Hz) is an important biomarker for malaria diagnosis, which is the by-product of a detoxification mechanism in the malaria parasite. This article highlights the importance of “Hz” for point-of-care malaria diagnosis when India and other countries are moving toward the goal of malaria elimination.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded29    
    Comments [Add]    

Recommend this journal